NCT03869905

Aquamin® as an Adjuvant Intervention for Ulcerative Colitis

Aquamin®, a Multi-mineral Natural Product From Red Marine Algae, as an Adjuvant Intervention for Mild Ulcerative Colitis and Ulcerative Colitis in Remission

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Muhammad N Aslam, MD · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if Aquamin® works as a potential treatment to improve symptoms and if it will induce remission in patients with mild Ulcerative Colitis and extend remission in Ulcerative Colitis in remission.

Conditions

• Ulcerative Colitis

Interventions

Type	Name	Description
DRUG	Aquamin®	4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day)
DRUG	Placebo first then Aquamin®	4 capsules per day; 2 to be taken in the morning and 2 in the evening

Timeline

• Start date: 2019-08-08
• Primary completion: 2027-12-01
• Completion: 2027-12-01
• First posted: 2019-03-11
• Last updated: 2026-01-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study